Business Description
Medfield Diagnostics AB
ISIN : SE0004479046
Compare
Compare
Traded in other countries / regions
MEDF.Sweden IPO Date
2012-05-02Description
Medfield Diagnostics AB develops, markets and sells diagnostic instrumentation based on microwave technology. The company researches the use of microwave technology in stroke diagnostics. Its products consist of Strokefinder and Impending Applications.
Financial Strength
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | No Debt | |||||
| Equity-to-Asset | 0.97 | |||||
| Piotroski F-Score | 4/9 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | -37 | |||||
| 3-Year EBITDA Growth Rate | 9.2 | |||||
| 3-Year EPS without NRI Growth Rate | 4.9 | |||||
| 3-Year FCF Growth Rate | 22.4 | |||||
| 3-Year Book Growth Rate | -16 |
Momentum Rank
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 49.38 | |||||
| 9-Day RSI | 45.51 | |||||
| 14-Day RSI | 43.67 | |||||
| 6-1 Month Momentum % | -40.77 | |||||
| 12-1 Month Momentum % | -88.38 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 2.86 | |||||
| Quick Ratio | 1.52 | |||||
| Cash Ratio | 1.04 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -34 |
Profitability Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| FCF Margin % | -2074.75 | |||||
| ROE % | -23.64 | |||||
| ROA % | -22.52 | |||||
| ROIC % | -22.42 | |||||
| ROC (Joel Greenblatt) % | -2000.04 | |||||
| ROCE % | -23.05 |
GF Value Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PS Ratio | 19.78 | |||||
| PB Ratio | 0.2 | |||||
| Price-to-Tangible-Book | 2.97 | |||||
| EV-to-EBIT | -0.42 | |||||
| EV-to-EBITDA | -0.47 | |||||
| EV-to-Revenue | 9.83 | |||||
| EV-to-FCF | -0.47 | |||||
| Price-to-Net-Current-Asset-Value | 2.97 | |||||
| Earnings Yield (Greenblatt) % | -238.1 | |||||
| FCF Yield % | -104.74 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Medfield Diagnostics AB Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil kr) | 0.713 | ||
| EPS (TTM) (kr) | -0.253 | ||
| Beta | 0 | ||
| Volatility % | 121.16 | ||
| 14-Day RSI | 43.67 | ||
| 14-Day ATR (kr) | 0.022677 | ||
| 20-Day SMA (kr) | 0.1882 | ||
| 12-1 Month Momentum % | -88.38 | ||
| 52-Week Range (kr) | 0.1305 - 2.324 | ||
| Shares Outstanding (Mil) | 79.35 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 4 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Medfield Diagnostics AB Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Medfield Diagnostics AB Stock Events
| Event | Date | Price(kr) | ||
|---|---|---|---|---|
| No Event Data | ||||
Medfield Diagnostics AB Frequently Asked Questions
What is Medfield Diagnostics AB(XSAT:MEDF)'s stock price today?
The current price of XSAT:MEDF is kr0.18. The 52 week high of XSAT:MEDF is kr2.32 and 52 week low is kr0.13.
When is next earnings date of Medfield Diagnostics AB(XSAT:MEDF)?
The next earnings date of Medfield Diagnostics AB(XSAT:MEDF) is 2025-02-21.
Does Medfield Diagnostics AB(XSAT:MEDF) pay dividends? If so, how much?
Medfield Diagnostics AB(XSAT:MEDF) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers